Entera Bio Ltd. (ENTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 60K 120K 180K Q3 '21: 140K Q4 '21: 165K Q1 '22: 68K Q2 '22: 44K Q3 '22: 8K Q4 '22: 14K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 57K Q3 '24: 42K Q4 '24: 82K Q1 '25: 42K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 30K 60K 90K Q3 '21: 75K Q4 '21: 29K Q1 '22: 14K Q2 '22: 11K Q3 '22: 2K Q4 '22: 6K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 9K Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -3.2M Q4 '21: -4.1M Q1 '22: -3.8M Q2 '22: -3.2M Q3 '22: -2.9M Q4 '22: -3.1M Q1 '23: -2.2M Q2 '23: -2.3M Q3 '23: -2.4M Q4 '23: -2M Q1 '24: -2.1M Q2 '24: -2.2M Q3 '24: -3M Q4 '24: -2.3M Q1 '25: -2.6M Q2 '25: -2.7M Q3 '25: -3.3M Q4 '25: -3M Q1 '26: -3.5M Q2 '26: -4.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -3.2M Q4 '21: -4.1M Q1 '22: -3.8M Q2 '22: -3.2M Q3 '22: -3.1M Q4 '22: -3M Q1 '23: -2.2M Q2 '23: -2.3M Q3 '23: -2.4M Q4 '23: -2M Q1 '24: -2M Q2 '24: -2.1M Q3 '24: -3M Q4 '24: -2.4M Q1 '25: -2.6M Q2 '25: -2.7M Q3 '25: -3.2M Q4 '25: -3M Q1 '26: -3.5M Q2 '26: -7.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 50K 100K 150K Q3 '21: 65K Q4 '21: 136K Q1 '22: 54K Q2 '22: 33K Q3 '22: 6K Q4 '22: 8K Q1 '23: 0 Q2 '23: 0 Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 48K Q3 '24: 42K Q4 '24: 82K Q1 '25: 42K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q1 '26: 0 Q2 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -2.1M Q4 '21: -2.5M Q1 '22: -4.8M Q2 '22: -2.8M Q3 '22: -2.9M Q4 '22: -2M Q1 '23: -1.6M Q2 '23: -1.6M Q3 '23: -1.5M Q4 '23: -2.6M Q1 '24: -1.9M Q2 '24: -1.3M Q3 '24: -2.2M Q4 '24: -1.5M Q1 '25: -1.4M Q2 '25: -1.6M Q3 '25: -2.5M Q4 '25: -1.8M Q1 '26: -3.1M Q2 '26: -3.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -2.1M Q4 '21: -2.5M Q1 '22: -4.8M Q2 '22: -2.8M Q3 '22: -2.9M Q4 '22: -2M Q1 '23: -1.6M Q2 '23: -1.6M Q3 '23: -1.5M Q4 '23: -2.6M Q1 '24: -1.9M Q2 '24: -1.3M Q3 '24: -2.2M Q4 '24: -1.5M Q1 '25: -1.4M Q2 '25: -1.7M Q3 '25: -2.5M Q4 '25: -1.9M Q1 '26: -3.1M Q2 '26: -3.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '19: 11.7M Q2 '20: 18.2M Q2 '21: 24.7M Q3 '21: 28.7M Q1 '22: 28.8M Q2 '22: 28.8M Q3 '22: 28.8M Q1 '23: 28.8M Q2 '23: 28.8M Q3 '23: 28.8M Q1 '24: 36.7M Q2 '24: 37.1M Q3 '24: 37.6M Q1 '25: 43.4M Q2 '25: 46.8M Q3 '25: 47.1M Q1 '26: 47.8M Q2 '26: 50.5M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.20 0.40 0.60 Q4 '21: 0.46 Q1 '22: 0.49 Q2 '22: 0.50 Q3 '22: 0.50 Q4 '22: 0.45 Q1 '23: 0.40 Q2 '23: 0.37 Q3 '23: 0.34 Q4 '23: 0.31 Q1 '24: 0.28 Q2 '24: 0.26 Q3 '24: 0.26 Q4 '24: 0.25 Q1 '25: 0.26 Q2 '25: 0.26 Q3 '25: 0.25 Q4 '25: 0.26 Q1 '26: 0.27 Q2 '26: 0.35 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.